SV

Street Verdict

Analyst Scorecard

A record of what Marketsmith India Analysis said publicly, with the source. Not advice.

“Recommends buying Krishna Institute of Medical Sciences Ltd. at ₹662.75, targeting ₹760 in three months with a stop loss at ₹615, citing strong financial performance, operational efficiency, and technical rebound after reclaiming its 21-DMA. Regulatory and operational risks in new facilities are noted.”

Marketsmith India Analysis’s track record (trackable calls only): 322 graded calls · 95% CI 22–32%

Krishna Institute of Medical Sciences Ltd.BullishCalled 22 May 2025Graded 18 Jul 2025
Verdict:HIT

How this call is judged

A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate.

No entry price is stated, so the call starts at the first close after it was published.

Target ₹760, stop ₹615, as stated.

Window: 90 days, the time frame the call states ("three months").

The target ₹760 was reached on a close before the stop ₹615. Hit.

The grader’s working: R4 TARGET_CALL: entered ₹672.9 on 2025-05-23 (next trading session's close); target ₹760 reached at close ₹761.25 on 2025-07-18. Window 90 days — rule H1: the quote states "three months".

Tracking Krishna Institute of Medical Sciences Ltd. since this call

1-year tracking window
Read the original articleSee Marketsmith India Analysis’s full track record